Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/6/2025

Naproxen Dosing and Duration for Costochondritis

Specific Dosing Recommendations

  • The European League Against Rheumatism recommends evaluating treatment response at 2-4 weeks, as this allows for assessment of the effectiveness of naproxen in managing costochondritis symptoms 1, 2
  • If sufficient response is achieved, the American College of Rheumatology suggests continuing treatment and reassessing at 12 weeks, to determine the need for ongoing therapy 1, 2
  • The European League Against Rheumatism recommends considering tapering or switching to on-demand use if sustained improvement occurs, to minimize the risk of adverse effects 1, 2

Critical Safety Considerations

  • The American Gastroenterological Association recommends adding a proton pump inhibitor or considering a COX-2 selective agent in patients with increased GI risk, such as those over 65 years old or with a history of ulcers 3, 4
  • The American Heart Association suggests using naproxen with caution in patients with cardiovascular disease, hypertension, or renal impairment, due to the increased risk of adverse cardiovascular and renal effects 3, 4
  • The National Kidney Foundation recommends avoiding long-term continuous use of naproxen beyond what is necessary for symptom control, to minimize the risk of renal impairment 5, 3, 4

Common Pitfalls to Avoid

  • The American College of Rheumatology recommends not combining naproxen with other NSAIDs, as this increases toxicity without improving efficacy 6